Theravance Biopharma, Inc. (TBPH)
17.03
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Theravance Biopharma Price : 17.03 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Oct 01, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Sep 30, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Sep 29, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Sep 28, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Sep 25, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Sep 24, 2026 | 17.03 | 17.03 | 17.03 | 17.03 | 0.000 |
| Sep 23, 2026 | 17.06 | 17.07 | 17.02 | 17.03 | 10.04M |
| Sep 22, 2026 | 17.04 | 17.08 | 17.03 | 17.03 | 6.187M |
| Sep 21, 2026 | 17.03 | 17.07 | 17.03 | 17.05 | 667296.0 |
| Sep 18, 2026 | 17.03 | 17.05 | 17.02 | 17.02 | 683740.0 |
| Sep 17, 2026 | 17.04 | 17.04 | 17.02 | 17.04 | 306994.0 |
| Sep 16, 2026 | 17.04 | 17.04 | 17.02 | 17.03 | 461692.0 |
| Sep 15, 2026 | 17.02 | 17.06 | 17.02 | 17.04 | 403744.0 |
| Sep 14, 2026 | 17.01 | 17.05 | 17.01 | 17.03 | 243262.0 |
| Sep 11, 2026 | 17.06 | 17.06 | 17.00 | 17.01 | 426795.0 |
| Sep 10, 2026 | 17.05 | 17.05 | 17.00 | 17.02 | 333931.0 |
| Sep 09, 2026 | 17.07 | 17.08 | 17.04 | 17.06 | 264266.0 |
| Sep 08, 2026 | 17.08 | 17.10 | 17.06 | 17.06 | 251661.0 |
| Sep 04, 2026 | 17.26 | 17.26 | 17.07 | 17.08 | 160550.0 |
| Sep 03, 2026 | 17.07 | 17.10 | 17.05 | 17.08 | 301866.0 |
| Sep 02, 2026 | 17.06 | 17.08 | 17.02 | 17.07 | 566896.0 |
| Sep 01, 2026 | 17.08 | 17.08 | 17.02 | 17.03 | 870673.0 |
| Aug 31, 2026 | 17.03 | 17.08 | 17.03 | 17.04 | 383660.0 |
| Aug 28, 2026 | 17.04 | 17.06 | 17.02 | 17.05 | 414568.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viatris, Inc. | 17.60 |
| Ocular Therapeutix, Inc. | 6.96 |
| ANI Pharmaceuticals, Inc. | 72.18 |
| Corcept Therapeutics, Inc. | 116.23 |
| Veru, Inc. | 2.51 |
Price Related Metrics
| PE Ratio | 16.87 |
| PS Ratio | 8.486 |
| PEG Ratio | 0.0509 |
| Price to Book Value | 3.050 |
| Price to Free Cash Flow | 16.47 |
| Earnings Yield | 5.93% |
| Market Cap | 883.70M |
| PEGY Ratio | 0.0509 |
| Operating PE Ratio | 400.71 |
| Normalized PE Ratio | 14.24 |